Table 1.
Baseline characteristics of ASCVD patients using moderate-/high-intensity statins, by annual cohort
| Characteristics | 2012 (n = 14,058) | 2013 (n = 15,383) | 2014 (n = 16,316) | |||
|---|---|---|---|---|---|---|
| n | % | n | % | n | % | |
| Age, mean (SD) | 70.6 (10.4) | 70.6 (10.5) | 70.8 (10.6) | |||
| Female | 4977 | 35.4 | 5,276 | 34.3 | 5629 | 34.5 |
| Private health insurance coverage | 1195 | 8.5 | 1,323 | 8.6 | 1371 | 8.4 |
| High-intensity statin use | 1130 | 8.0 | 1629 | 10.6 | 1956 | 12.0 |
| Ezetimibe use | 1136 | 9.5 | 1209 | 7.9 | 1107 | 6.8 |
| Type 2 diabetes | 4414 | 31.4 | 4646 | 30.2 | 5042 | 30.9 |
| Hypertension | 10,558 | 75.1 | 11,399 | 74.1 | 12,123 | 74.3 |
| Coronary heart disease | 9827 | 69.9 | 10,676 | 69.4 | 11,274 | 69.1 |
| Myocardial infarction | 3233 | 23.0 | 3615 | 23.5 | 3671 | 22.5 |
| Ischemic stroke | 731 | 5.2 | 831 | 5.4 | 946 | 5.8 |
| Peripheral artery disease | 2095 | 14.9 | 2184 | 14.2 | 2496 | 15.3 |
| Chronic kidney disease | 548 | 3.9 | 646 | 4.2 | 767 | 4.7 |
| COPD | 1237 | 8.8 | 1431 | 9.3 | 1566 | 9.6 |
| Heart failure | 1870 | 13.3 | 2046 | 13.3 | 2350 | 14.4 |
| Depression | 1434 | 10.2 | 1615 | 10.5 | 1811 | 11.1 |
| Charlson Comorbidity Index mean (SD) | 1.8 (1.4) | 1.8 (1.4) | 1.9 (1.5) | |||
COPD chronic obstructive pulmonary disease, SD standard deviation